The company reported on Tuesday that its revenues jumped 8 percent in North America and Europe during the third quarter but fell slightly in the rest of the world.
Collaboration will expand access to high sensitivity NULISA immunoassays for clinical biomarker analysis. GENT, Belgium & FREMONT, Calif.--BUSINESS ...
The global sepsis diagnostics market was valued at US $54 million in the year 2020 and is expected to be worth at US $142 billion by the year 2030. The market is thriving at a compound annual growth ...
Report Ocean has published a new report on the Saudi Arabia Automated Microbiology Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The ...
The recombinant was demonstrated to be highly attenuated in tissue culture and in vivo. It has thus been proposed as a safe surrogate for SARS-CoV-2 (a BSL-3 agent) in immunoassays and as a candidate ...